SMITH & NEPHEW PLC SNN

Latest FY: 2025 Healthcare Medical Devices
Market Price $27.61
Market Cap $11.75B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑6.1% YoY
$6.16B
3-Yr CAGR: 5.7%
Net Income ↑56.4% YoY
$779.00M
Net Margin: 12.6%
Free Cash Flow ↓-20.7% YoY
-$291.00M
FCF Yield: -2.48%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
N/A
ROA: 7.4%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (SNN)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $4,669.0M $3,397.0M $1,062.0M 0.00% $48.0M $-344.0M
FY 2017 $4,765.0M +2.1% $3,517.0M $879.0M -17.2% 0.00% $50.0M $-326.0M +5.2%
FY 2018 $4,904.0M +2.9% $3,606.0M $781.0M -11.1% 0.00% $54.0M $-293.0M +10.1%
FY 2019 $5,138.0M +4.8% $3,800.0M $743.0M -4.9% 0.00% $56.0M $-352.0M -20.1%
FY 2020 $4,560.0M -11.2% $3,164.0M $246.0M -66.9% 0.00% $61.0M $-382.0M -8.5%
FY 2021 $5,212.0M +14.3% $3,669.0M $586.0M +138.2% 0.00% $80.0M $-328.0M +14.1%
FY 2022 $5,215.0M +0.1% $3,675.0M $235.0M -59.9% 0.00% $73.0M $-285.0M +13.1%
FY 2023 $5,549.0M +6.4% $3,819.0M $290.0M +23.4% 0.00% $104.0M $-323.0M -13.3%
FY 2024 $5,810.0M +4.7% $4,046.0M $498.0M +71.7% 0.00% $140.0M $-241.0M +25.4%
FY 2025 $6,164.0M +6.1% $4,192.0M $779.0M +56.4% 0.00% $142.0M $-291.0M -20.7%
$

Valuation

Market Price $27.61
Market Cap $11.75B
Enterprise Value N/A
P/E Ratio N/A
P/B Ratio N/A
FCF Yield -2.48%
Dividend Yield 0.00%
Shares Outstanding 425,440,600
%

Profitability & Margins

Gross Margin 68.01%
Operating Margin 12.88%
Net Margin 12.64%
Return on Equity (ROE) N/A
Return on Assets (ROA) 7.45%
Asset Turnover 0.59x
Revenue 3-Yr CAGR 5.73%
🛡️

Financial Health & Liquidity

Current Ratio 0.08
Cash Ratio N/A
Debt / Equity N/A
Debt / Assets 0.000
Cash & Equivalents N/A
Total Debt N/A
Book Value / Share N/A
💧

Cash Flow Efficiency

Operating Cash Flow $142.00M
Capital Expenditures (CapEx) $433.00M
Free Cash Flow -$291.00M
OCF / Revenue 2.30%
FCF / Revenue -4.72%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share N/A
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $10.46B
Total Liabilities $5.17B
Stockholders' Equity N/A
Current Assets $16.00M
Current Liabilities $194.00M